Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)

EPA:ALOPM Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	0.45	0.44	0.32	13.37
Short-Term Investments	2	4.84	10.01	-
Cash & Short-Term Investments	2.45	5.27	10.34	13.37
Cash Growth	-	-48.99%	-22.72%	-
Accounts Receivable	0.39	0.62	1.06	0.48
Other Receivables	1.75	2.3	2.68	2.41
Receivables	2.14	2.92	3.74	2.89
Prepaid Expenses	0.21	0.46	0.32	0.14
Other Current Assets	0	0	-	-
Total Current Assets	17.81	8.66	14.4	16.41
Property, Plant & Equipment	0.56	0.63	0.76	0.9
Long-Term Investments	0.04	0.08	0.06	-
Other Intangible Assets	1.07	1.08	1.15	0.79
Other Long-Term Assets	0.11	0.26	0.26	0.27
Total Assets	19.59	10.71	16.63	18.37
Accounts Payable	1.42	2.24	2.89	2.98
Current Income Taxes Payable	0.95	0.85	1.19	0.98
Other Current Liabilities	-	0.34	-	-
Total Current Liabilities	2.37	3.43	4.08	3.96
Long-Term Debt	6.53	7.58	8.83	2.6
Long-Term Unearned Revenue	0.29	0.13	0.03	-
Other Long-Term Liabilities	-	-	0	0.02
Total Liabilities	9.2	11.14	12.94	6.59
Common Stock	1.82	6.22	5.7	5.68
Additional Paid-In Capital	-	5.59	4.37	4.39
Retained Earnings	4.31	-15.53	-8.32	-0.23
Comprehensive Income & Other	4.27	3.29	1.94	1.94
Shareholders' Equity	10.39	-0.43	3.69	11.78
Total Liabilities & Equity	19.59	10.71	16.63	18.37
Total Debt	6.53	7.58	8.83	2.6
Net Cash (Debt)	-4.08	-2.31	1.51	10.77
Net Cash Growth	-	-	-85.98%	-
Net Cash Per Share	-0.23	-0.13	0.09	0.65
Filing Date Shares Outstanding	18.12	18.17	16.66	16.59
Total Common Shares Outstanding	18.12	18.17	16.63	16.59
Working Capital	15.44	5.24	10.32	12.45
Book Value Per Share	0.57	-0.02	0.22	0.71
Tangible Book Value	9.32	-1.51	2.54	10.99
Tangible Book Value Per Share	0.51	-0.08	0.15	0.66
Land	0.11	0.11	0.11	0.11
Buildings	0.25	0.25	0.25	0.24
Machinery	0	0	0	0.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.